PMD-200TM

Monitoring physiological pain response to enhance recovery

Accurate, continuous and noninvasive nociception monitoring

Leveraging NOL technology, the PMD-200™ monitoring device quantifies the patient’s physiological response to pain.

The PMD-200 is designed for the operating room and critical care settings, where patients under general anaesthesia are unable to communicate their pain. The system enables clinicians to assess nociception and titrate analgesic medications during anaesthesia – avoiding excessive use or underuse and correlated adverse events.

Clinical studies^1,2,3 have shown that compared to standard of care, NOL-guided analgesia can contribute to:

Play Video

How It Works

Stand-alone or connected with Philips IntelliVue patient monitors

User-friendly UI
Available in 12 languages

Commercially available in Europe, Canada, Australia, Israel, Turkey, Latin America

What experts are saying

"NOL can make over- and under-analgesia less likely and opioid dosing safer, especially in high-risk and opioid-tolerant patients."

Frank J. Overdyk, MSEE, MDExecutive Director for Research, Department of Anesthesiology, North Shore-LIJ Health System. Attending Anesthesiologist, North Shore University Hospital and Long Island Jewish Medical Center

"Getting the right dose of anti-nociceptive medications matters. Too little, and patients wake up in pain. Too much, and patients are at risk of drug-related complications."

Prof. Daniel SesslerHead of Department of Outcomes Research, Cleveland Clinic, Ohio, USA. A member of Medasense’s advisory board

"Our study confirmed that the NOL gives a better assessment of the patient’s nociceptive state than the parameters we currently use in the operating theatre."

Dr. Ruth EdryHead of Acute Pain Service, Anesthesiology, Rambam Medical Center, Haifa, Israel

"I feel confident using NOL and BIS monitoring intraoperatively to keep depth of anaesthesia and analgesia within clinical targets at all times and ensuring effective analgesia."

Prof. Anil HormisConsultant in Anaesthesia, Critical Care and Pre-hospital Emergency Medicine, Rotherham NHS Foundation Trust, UK

"It is clear that current pain assessment approaches in the operating room are limited. The NOL index provides anesthesiologists with a decision support tool to objectively assess and optimize the treatment of a patient’s nociception."

Prof. Albert Dahan, MD, PhDDepartment of Anaesthesiology, Leiden University Medical Center, The Netherlands

"I truly believe in the NOL technology. I am convinced it will improve the quality of our anesthesia and impact patient recovery."

Prof. Philippe RichebéProfessor and Anesthesiologist, Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, Canada

"NOL enables direct, rapid monitoring, and with regional anaesthesia indicates when we should check whether something is not in order, such as patient discomfort of some kind."

Dr. med. Doreen WiedemannDepartment of Anesthesiology and Intensive Care, Otto-von-Guericke-Universität Magdeburg, Germany

How NOL monitoring helps guide TIVA TCI anaesthesia | Dr. Hugo Vereecke

NOL guided analgesia in daily practice with Prof. Philippe Richebé

TV News: Patients in Portugal are getting customized anaesthesia care with NOL

REFERENCES:

1. Meijer, F., Honing, M., Roor, T., Toet, S., Calis, P., Olofsen, E., Martini, C., van Velzen, M., Aarts, L.,
Niesters, M., Boon, M., Dahan, A. (2020). Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane
anaesthesia: a randomised controlled trial. British Journal of Anaesthesia [In Press]

2. Meijer, F., Martini, C., Broens, S., Boon, M., Niesters, M., Aarts, L., Olofsen, E., van Velzen, M., Dahan, A. (2019). Nociception-guided versus Standard Care during Remifentanil–Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology, 130(5), 745-755. doi:10.1097/ALN.0000000000002634

3. Saunders R., Weissbrod R. (2020). Cost benefit of personalizing intraoperative pain management. Presented at ISPOR Virtual Conference, May 2020